CAS 1847394-95-9

Setrusumab

CAS: 1847394-95-9

Pureza: 95%

Ref: IN-DA02EOAW

Setrusumab

CAS: 1847394-95-9

Setrusumab (BPS 804) is a sclerostin-targeting antibody used in bone remodeling and Wnt signaling research.

Pureza: >95% (SDS-PAGE); 97.8% (SEC-HPLC) - >95% (SDS-PAGE); 97.8% (SEC-HPLC)

Cor e Forma: Liquid

Peso molecular: 143.42 kDa (Predicted)

Ref: TM-T81173